Aminoverse B.V.

Aminoverse is all about enzymes. Aminoverse B.V. is a Dutch biotechnology contract research organization (CRO) founded in 2020, specializing in enzyme research and development. The company provides a comprehensive suite of services that bridges the gap between laboratory-scale scientific discovery and industrial-scale application. By integrating a proprietary approach that combines wet-lab experiments, state-of-the-art in silico design, and AI-driven platforms, Aminoverse identifies and optimizes biocatalysts for specific chemical reactions, and application in products. This multidisciplinary strategy enables them to reduce development timelines, lower project risks, and address common bottlenecks in biocatalytic process engineering.

Operating as a customer-centric partner, Aminoverse functions as a temporary extension of a client's own R&D team, providing support for feasibility studies, robust assay development, and custom enzyme panel generation. Their business model emphasizes transparency and IP retention for clients, operating on a fee-for-service basis without royalties. Serving industries across pharmaceuticals, fine chemicals, nutraceuticals, flavor and fragrances, and feed, the company leverages its expertise to transform enzyme science into practical, cost-efficient, and sustainable industrial manufacturing processes and products. They also provide off-the-shelf enzyme kits for research applications, to facilitate the entrance into biocatalysis.